Activity of interferon-alpha and isotretinoin in patients with advanced, refractory lymphoid malignancies.
about
Isotretinoin--unapproved indications/uses and dosage: a physician's reference.Systemic chemo-immunotherapy for advanced-stage hepatocellular carcinoma.Retinoid X receptor α attenuates host antiviral response by suppressing type I interferon.Not every patient needs a triglyceride check, but all can get pancreatitis: a systematic review and clinical characterization of isotretinoin-associated pancreatitis.
P2860
Activity of interferon-alpha and isotretinoin in patients with advanced, refractory lymphoid malignancies.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Activity of interferon-alpha a ...... ractory lymphoid malignancies.
@ast
Activity of interferon-alpha a ...... ractory lymphoid malignancies.
@en
type
label
Activity of interferon-alpha a ...... ractory lymphoid malignancies.
@ast
Activity of interferon-alpha a ...... ractory lymphoid malignancies.
@en
prefLabel
Activity of interferon-alpha a ...... ractory lymphoid malignancies.
@ast
Activity of interferon-alpha a ...... ractory lymphoid malignancies.
@en
P50
P356
P1433
P1476
Activity of interferon-alpha a ...... ractory lymphoid malignancies.
@en
P2093
Jorge Romaguera
Madeleine Duvic
P304
P356
10.1002/CNCR.20009
P407
P577
2004-02-01T00:00:00Z